$3.87
0.195.16%
Last update: Sep 23, 9:01 AM
15 minutes delayed
Matinas BioPharma Hldgs reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Matinas BioPharma Hldgs using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-14 | $-1.00 | $-1.00 | 0.00 % |
Mar 2024 | 2024-05-09 | $-1.50 | $-1.50 | 0.00 % |
Sep 2023 | 2023-11-08 | $-1.50 | $-1.50 | 0.00 % |
Jun 2023 | 2023-08-09 | $-1.50 | $-1.50 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Mar 2023 | 2023-05-10 | $1.10M | $300.00K | 265.3 % |
Dec 2022 | 2023-03-15 | $1.06M | $1.10M | -3.36 % |
Sep 2022 | 2022-11-02 | $0 | $830.00K | -100.0 % |
Jun 2022 | 2022-08-11 | $1.06M | $100.00K | 963.0 % |
Matinas BioPharma Hldgs (MTNB) is scheduled to report earnings on November 6, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.
The Actual EPS was $-1.00, which hit the estimate of $-1.00.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.